CompletedEUCTR 2006-004073-10
Effect of Atomoxetine and a standardized behavior therapy on attention deficits in adult ADHD
This historical record does not confirm current site availability.
Historical research recordGermany
Understand this study
What did researchers investigate?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Germany
- Study phase
- Phase 3 / Phase 4This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateNot clearly listed
- Recruitment status
- Completed
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- University of Giessen
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3, Phase 4This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- Germany
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2006-004073-10
- Official title
Show the full official title
Effect of Atomoxetine and a standardized behavior therapy on attention deficits in adult ADHD
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Germany
Registry details
Historical country statuses
- Germany — Completed
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Giessen, a university.
